血管性痴呆

Bowler JV. Modern concept of vascular cognitive impairment. Br Med Bull. 2007;83:291-305.

• 摘要

Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke - Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241.

• 全文
• 摘要

Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;(1):CD005593.

• 全文
• 摘要

1.  Bowler JV. Modern concept of vascular cognitive impairment. Br Med Bull. 2007;83:291-305.

• 摘要

2.  Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke - Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241.

• 全文
• 摘要

3.  Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies; report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.

• 摘要

4.  American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

5.  Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125-132.

• 摘要

6.  Hagnell O, Franck A, Grasbeck A, et al. Vascular dementia in the Lunby study: 1. a prospective, epidemiological study of incidence and risk from 1957-1972. Neuropsychobiology. 1992;26:43-49.

• 摘要

7.  Gorelick PB, Brody JA, Cohen DC, et al. Risk factors for dementia associated with multiple cerebral infarcts: a case-control analysis in predominantly African-American hospital-based patients. Arch Neurol. 1993;50:714-720.

• 摘要

8.  Brundel M, de Bresser J, van Dillen JJ, et al. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab. 2012;32:425-436.

• 摘要

9.  Wallin A, Milos V, Sjogren M, et al. Classification and subtypes of vascular dementia. International Psychogeriatrics. 2003;15:27-37.

• 摘要

10.  Horowitz DR, Tuhrim S, Weinberger JM, et al. Mechanisms in lacunar infarction. Stroke. 1992;23:325-327.

• 摘要

11.  Braffman BH, Zimmerman RA, Trojnowski JQ, et al. Brain MR: pathologic correlation with gross and histopathology. II. Hyperintense white matter foci in the elderly. AJR Am J Roentgenol. 1988;151:559-566.

• 全文
• 摘要

12.  Bateman GA. Pulse-wave encephalopathy: a comparative study of the hydrodynamics of leukoaraiosis and normal pressure hydrocephalus. Neuroradiology. 2002;44:740-748.

• 摘要

13.  Lee SH, Kim SM, Kim N, et al. Cortico-subcortical distribution of microbleeds is different between hypertension and cerebral amyloid angiopathy. J Neurol Sci . 2007;258:111-114.

• 摘要

14.  Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci. 2007;257:80-87.

• 摘要

15.  Tatemichi TK, Desmond DW, Paik M, et al. Clinical determinants of dementia related to stroke. Ann Neurol. 1993;33:568-575.

• 摘要

16.  White L, Petrovitch H, Ross GW, et al. Prevalence of dementia in older Japanese American men in Hawaii: the Honolulu-Asia aging study. JAMA. 1996;276:955-960.

• 摘要

17.  Whitmer RA, Gunderson EP, Quesenberry CP, et al. Body mass index in midlife and risk of Alzheimer's disease and vascular dementia. Curr Alzheimer Res. 2007;4:103-109.

• 摘要

18.  Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.

• 摘要

19.  Guo Z, Viitanen M, Fratiglioni L, et al. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 1996;312:805-808.

• 摘要

20.  Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al. Clinical determinants of post stroke dementia. Stroke. 1998;29:75-81.

• 摘要

21.  Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology. 1995;45:1161-1168.

• 摘要

22.  Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003 Oct 13;163(18):2219-29.

• 全文
• 摘要

23.  Hejl AM, Hogh P, Waldemar G. Potentially reversible conditions in 1000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry. 2002;73:390-394.

• 全文
• 摘要

24.  Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160-2236.

• 全文
• 摘要

25.  Rands G, Orrell M. Aspirin for vascular dementia. Cochrane Database Syst Rev. 2000;(4):CD001296.

• 全文
• 摘要

26.  Hankey GJ. Clinical update: Management of stroke. Lancet. 2007;369:1330-1332.

• 摘要

27.  Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006 May 20;367(9523):1665-73.

• 摘要

28.  Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and asprin vs asprin alone for the protection of atherothrombotic events. N Engl J Med. 2006;354:1706-1717.

• 摘要

29.  Brott TG, Brown RD, Meyer FB, et al. Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting. Mayo Clin Proc. 2004 Sep;79(9):1197-208.

• 摘要

30.  Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998 Nov 12;339(20):1415-25.

• 全文
• 摘要

31.  Demaerschalk BM, Wingerchuk DM. Treatment of vascular dementia and vascular cognitive impairment. Neurologist. 2007;13:37-41.

• 摘要

32.  Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol. 2007;6:782-792.

• 摘要

33.  Korczyn AD. Drugs for vascular dementia. Lancet Neurol. 2007;6:749-751.

• 摘要

34.  Black SE. Therapeutic issues in vascular dementia: studies, designs and approaches. Can J Neurol Sci. 2007;34(suppl 1):S125-S130.

• 摘要

35.  Wilkinson D, Róman G, Salloway S, et al. The long-term efficacy and tolerability of donepezil in patients with vascular dementia. Int J Geriatr Psychiatry. 2010;25:305-313.

• 摘要

36.  Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;(1):CD005593.

• 全文
• 摘要

37.  Holmes C, Cairns N, Lantos P, et al. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry. 1999; 174:45-50.

• 摘要

38.  Hanon O, Forette F. Prevention of dementia: lessons from SYST-EUR and PROGRESS. J Neurol Sci. 2004;226:71-74.

• 摘要

39.  López Arrieta J, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev. 2002;(3):CD000147.

• 全文
• 摘要

40.  Shah K, Qureshi SU, Johnson M, et al. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother. 2009;7:250-261.

• 摘要

41.  McGuinness B, Todd S, Passmore P, et al. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev. 2009;(4):CD004034.

• 全文
• 摘要

42.  Etminan M, Gill S, Sammii A. The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies. Pharmacotherapy. 2003;23:726-730.

• 摘要

43.  Bernick C, Katz R, Smith NL, et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology. 2005;65:1388-1394.

• 摘要

44.  McGuinness B, Craig D, Bullock R, et al. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;(1):CD003160.

• 全文
• 摘要

45.  Amarenco P, Bogousslavsky J, Callahan A 3rd, et al; The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. 2006 Aug 10;355(6):549-59.

• 全文
• 摘要

46.  Aarsland D, Sardahaee FS, Anderssen S, et al. Is physical activity a potential preventive factor for vascular dementia? A systematic review. Aging Ment Health. 2010;14:386-395.

• 摘要

47.  Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-2962.

• 全文
• 摘要

48.  Kasper S, Schubert H. Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability [in German]. Fortschr Neurol Psychiatr. 2009;77:494-506.

• 摘要

49.  Weinmann S, Roll S, Schwarzbach C, et al. Effects of ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr. 2010;10:14.

• 全文
• 摘要

50.  Guekht AB, Moessler H, Novak PH, et al. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. J Stroke Cerebrovasc Dis. 2011;20:310-318.

• 摘要

51.  Chen N, Yang M, Guo J, et al. Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2013;(1):CD008900.

• 全文
• 摘要

52.  Park JH, Lee SB, Lee JJ, et al. Depression in vascular dementia is quantitively and qualitatively different from depression in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007;23:67-73.

• 摘要

53.  O'Brien J. Behavioral symptoms in vascular cognitive impairment and vascular dementia. Int Psychogeriatr. 2003;15(suppl 1):133-138.

• 摘要

54.  Verghese J, Lipton RB, Hall CB. Abnormality of gait as a predictor of non-Alzheimer dementia. N Engl J Med. 2002;347:1761-1768.

• 摘要

55.  American Academy of Neurology. AAN guideline summary for clinicians: detection, diagnosis and management of dementia. February 2004. http://www.aan.com/ (last accessed 9 March 2017).

• 全文